vs

Side-by-side financial comparison of PAMT CORP (PAMT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PAMT CORP is the larger business by last-quarter revenue ($141.3M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -15.1%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-25.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -12.0%).

PAMT vs PBYI — Head-to-Head

Bigger by revenue
PAMT
PAMT
1.9× larger
PAMT
$141.3M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+42.9% gap
PBYI
27.7%
-15.1%
PAMT
More free cash flow
PBYI
PBYI
$39.4M more FCF
PBYI
$14.4M
$-25.0M
PAMT
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-12.0%
PAMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PAMT
PAMT
PBYI
PBYI
Revenue
$141.3M
$75.5M
Net Profit
$-29.3M
Gross Margin
69.3%
Operating Margin
-27.0%
22.7%
Net Margin
-20.7%
Revenue YoY
-15.1%
27.7%
Net Profit YoY
7.4%
EPS (diluted)
$-1.38
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PAMT
PAMT
PBYI
PBYI
Q4 25
$141.3M
$75.5M
Q3 25
$150.3M
$54.5M
Q2 25
$151.1M
$52.4M
Q1 25
$155.3M
$46.0M
Q4 24
$166.5M
$59.1M
Q3 24
$182.6M
$80.5M
Q2 24
$182.9M
$47.1M
Q1 24
$182.6M
$43.8M
Net Profit
PAMT
PAMT
PBYI
PBYI
Q4 25
$-29.3M
Q3 25
$-5.6M
$8.8M
Q2 25
$-9.6M
$5.9M
Q1 25
$-8.1M
$3.0M
Q4 24
$-31.6M
Q3 24
$2.4M
$20.3M
Q2 24
$-2.9M
$-4.5M
Q1 24
$281.0K
$-4.8M
Gross Margin
PAMT
PAMT
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
PAMT
PAMT
PBYI
PBYI
Q4 25
-27.0%
22.7%
Q3 25
-3.8%
17.6%
Q2 25
-7.3%
12.7%
Q1 25
-5.9%
8.7%
Q4 24
-22.6%
22.6%
Q3 24
1.3%
27.4%
Q2 24
-0.4%
-4.6%
Q1 24
-0.4%
-5.3%
Net Margin
PAMT
PAMT
PBYI
PBYI
Q4 25
-20.7%
Q3 25
-3.7%
16.2%
Q2 25
-6.4%
11.2%
Q1 25
-5.2%
6.5%
Q4 24
-19.0%
Q3 24
1.3%
25.2%
Q2 24
-1.6%
-9.6%
Q1 24
0.2%
-11.0%
EPS (diluted)
PAMT
PAMT
PBYI
PBYI
Q4 25
$-1.38
$0.26
Q3 25
$-0.27
$0.17
Q2 25
$-0.46
$0.12
Q1 25
$-0.37
$0.06
Q4 24
$-1.44
$0.40
Q3 24
$0.11
$0.41
Q2 24
$-0.13
$-0.09
Q1 24
$0.01
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PAMT
PAMT
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$83.7M
$97.5M
Total DebtLower is stronger
$333.9M
$22.7M
Stockholders' EquityBook value
$210.5M
$130.3M
Total Assets
$697.9M
$216.3M
Debt / EquityLower = less leverage
1.59×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PAMT
PAMT
PBYI
PBYI
Q4 25
$83.7M
$97.5M
Q3 25
$115.6M
$94.4M
Q2 25
$117.3M
$96.0M
Q1 25
$102.7M
$93.2M
Q4 24
$110.7M
$101.0M
Q3 24
$92.3M
$96.7M
Q2 24
$114.0M
$96.8M
Q1 24
$125.8M
$107.2M
Total Debt
PAMT
PAMT
PBYI
PBYI
Q4 25
$333.9M
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$325.6M
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PAMT
PAMT
PBYI
PBYI
Q4 25
$210.5M
$130.3M
Q3 25
$239.5M
$115.3M
Q2 25
$244.9M
$104.7M
Q1 25
$269.6M
$97.1M
Q4 24
$277.5M
$92.1M
Q3 24
$308.9M
$71.1M
Q2 24
$306.7M
$48.5M
Q1 24
$314.6M
$51.0M
Total Assets
PAMT
PAMT
PBYI
PBYI
Q4 25
$697.9M
$216.3M
Q3 25
$715.2M
$202.9M
Q2 25
$707.9M
$194.9M
Q1 25
$712.6M
$196.2M
Q4 24
$741.7M
$213.3M
Q3 24
$756.7M
$220.7M
Q2 24
$733.5M
$205.0M
Q1 24
$746.4M
$214.1M
Debt / Equity
PAMT
PAMT
PBYI
PBYI
Q4 25
1.59×
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
1.17×
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PAMT
PAMT
PBYI
PBYI
Operating Cash FlowLast quarter
$-5.8M
$14.4M
Free Cash FlowOCF − Capex
$-25.0M
$14.4M
FCF MarginFCF / Revenue
-17.7%
19.1%
Capex IntensityCapex / Revenue
13.6%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.4M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PAMT
PAMT
PBYI
PBYI
Q4 25
$-5.8M
$14.4M
Q3 25
$5.9M
$9.7M
Q2 25
$12.2M
$14.1M
Q1 25
$5.0M
$3.6M
Q4 24
$15.2M
$15.6M
Q3 24
$15.5M
$11.0M
Q2 24
$18.7M
$1.0M
Q1 24
$9.6M
$11.2M
Free Cash Flow
PAMT
PAMT
PBYI
PBYI
Q4 25
$-25.0M
$14.4M
Q3 25
$2.5M
$9.7M
Q2 25
$5.9M
$14.1M
Q1 25
$-6.8M
$3.6M
Q4 24
$-39.9M
$15.6M
Q3 24
$-33.6M
$11.0M
Q2 24
$4.1M
$1.0M
Q1 24
$-12.2M
FCF Margin
PAMT
PAMT
PBYI
PBYI
Q4 25
-17.7%
19.1%
Q3 25
1.7%
17.7%
Q2 25
3.9%
26.8%
Q1 25
-4.4%
7.7%
Q4 24
-24.0%
26.4%
Q3 24
-18.4%
13.7%
Q2 24
2.2%
2.1%
Q1 24
-6.7%
Capex Intensity
PAMT
PAMT
PBYI
PBYI
Q4 25
13.6%
0.0%
Q3 25
2.3%
0.0%
Q2 25
4.2%
0.0%
Q1 25
7.6%
0.1%
Q4 24
33.1%
0.0%
Q3 24
26.9%
0.0%
Q2 24
8.0%
0.0%
Q1 24
12.0%
0.0%
Cash Conversion
PAMT
PAMT
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
6.44×
0.54×
Q2 24
Q1 24
34.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons